Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2003
08/13/2003CN1117579C Plaster for treating common cold
08/12/2003US6605722 Tyrosine derivatives with anti-leukotrienen activity
08/12/2003US6605702 Protein for use in the treatment of inflammatory defects and asthma
08/12/2003US6605634 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
08/12/2003US6605633 Such as 5-Bromo-2-phenyl-1H-indole-3-butanoic acid
08/12/2003US6605623 Prevention of asthma and other allergic diseases
08/12/2003US6605613 Polyene macrolide antibiotic, especially a rapamycin, and an antioxidant, especially 2,6-di-t-butyl-4-methylphenol; 40-O-(2-hydroxy)ethyl-rapamycin in crystalline form.
08/12/2003US6605601 Hypotensive agents; cardiovascular disorders
08/12/2003US6605600 Diuretics
08/12/2003CA2212836C Substituted isoxazoles for the treatment of inflammation
08/07/2003WO2003065046A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
08/07/2003WO2003065044A2 Diagnostics and therapeutics for diseases associated with gpr72
08/07/2003WO2003064685A2 Genetic polymorphisms in the preprotachykinin gene
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064622A2 Aggrecanase molecules
08/07/2003WO2003064596A2 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003WO2003064458A2 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
08/07/2003WO2003064447A2 Immune-modulating peptide
08/07/2003WO2003064443A2 New corticosteroids
08/07/2003WO2003064425A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/07/2003WO2003064419A1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
08/07/2003WO2003064418A1 Anticholinergic agents, method for producing the same and use thereof as medicaments
08/07/2003WO2003064417A1 Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments
08/07/2003WO2003064411A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
08/07/2003WO2003064397A1 Indazole compounds useful as protein kinase inhibitors
08/07/2003WO2003064389A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
08/07/2003WO2003064387A2 Substituted indoles as alpha-1 agonists
08/07/2003WO2003064383A2 Phosphorus-containing compounds & uses thereof
08/07/2003WO2003064009A1 Portable oxygen concentrator
08/07/2003WO2003063911A1 Decoy-containing pharmaceutical compositions and method of using the same
08/07/2003WO2003063905A1 Preventives or remedies for immunological diseases
08/07/2003WO2003063900A1 Process for the preparation of a nutrient formulation
08/07/2003WO2003063893A2 Fgfr agonists
08/07/2003WO2003063875A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis
08/07/2003WO2003063861A1 Fibrosis inhibitor
08/07/2003WO2003063843A1 Composition for inhalation
08/07/2003WO2003063842A1 Composition for inhalation
08/07/2003WO2003063800A2 8-heteroaryl xanthine adenosine a2b receptor antagonists
08/07/2003WO2003063794A2 2,4-pyrimidinediamine compounds and their uses
08/07/2003WO2003063772A2 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
08/07/2003WO2003063758A2 Bicyclic cb2 cannabinoid receptor ligands
08/07/2003WO2003008640A3 Asthma-associated gene
08/07/2003WO2002055541A3 Peptides having inhibiting activity on the production of nitric oxide
08/07/2003WO2002004015A9 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
08/07/2003WO2002000172A3 Methods for using tetanus toxin for benificial purposes in animals (mammals)
08/07/2003US20030150005 Rodent model comprising genes coding hypoxia inducible factor (HIF) for detection of hypoxic tissue
08/07/2003US20030149998 Nucleotide sequences coding orphan receptors/membrane proteins OM-10 and UP-11 for detecting modulators of inflammation, nervous system activity and infection; antitumor/antiinflammatory agents; gene expression inhibition
08/07/2003US20030149242 Novel polypeptide
08/07/2003US20030149237 G-protein coupled receptor for treatment and prevention of eating, cancer, autoimmune, vision and nervous sytem disorders; antiinflammatory agents
08/07/2003US20030149113 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
08/07/2003US20030149108 Linked biaryl compounds
08/07/2003US20030149083 For therapy of inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic erythematodes, multiple sclerosis, Sjogren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis
08/07/2003US20030149081 For therapy and prophylaxis of asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, inflammatory bowel disease, atherosclerosis
08/07/2003US20030149067 Crystallisation of the desired crystalline form from a toluene/diethyl ether mixture comprising raw cabergoline, followed by recovery and drying of the resulting crystals
08/07/2003US20030149062 Therapy of inflammatory diseases of the airways or intestines which by administering substances selected from quinazoline derivatives, 4-((3-chloro-4-fluorophenyl)amino)-6-((4-dimethylamino-cyclohexyl)amino) -pyrimido(5,4-d)pyrimidine
08/07/2003US20030149056 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
08/07/2003US20030149051 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, cancer, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks
08/07/2003US20030149047 Novel compounds
08/07/2003US20030149039 For therapy of disease responsive to antagonist modulation of the Neurokinin-1 (NK-1) receptor in a patient
08/07/2003US20030149037 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc.
08/07/2003US20030149036 Substituted benzothiazole amide derivatives
08/07/2003US20030149026 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc.
08/07/2003US20030149007 For inducing bronchodilation or providing relief of bronchospasm
08/07/2003US20030149006 New vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
08/07/2003US20030148990 Administering a therapeutically effective amount of an epidermal growth factor receptor (EGF-R) antagonist for therapy of hypersecretion of mucus in lungs
08/07/2003US20030148976 For therapy of cancer, infectious disease, and allergic disorders
08/07/2003US20030148964 Single dose azithromycin
08/07/2003US20030148947 MIP as a research tool for identification, characterization and purification of molecules involved in cellular transport and osmotic regulation; agonists/antagonists; vision defects; anitinflammatory agents; nervous system and kidney disorders
08/07/2003US20030148945 Antimicrobial and anti-inflammatory peptides
08/07/2003US20030148934 Human growth factor modulators (GFMO) polynucleotides which identify and encode GFMO; amino acid sequences, expression vectors, host cells, antibodies, agonists, and antagonists; anticarcinogenic agents; fibrotic disorders
08/07/2003US20030148451 Endothelial differntiation gene 6-like g protein coupled receptor
08/07/2003US20030148327 Nucleic acid of given sequence; oligonucleotides and oligomers for detecting the cytosine methylation of genes; tumors and cancer
08/07/2003US20030148326 Diagnosis of diseases associated with dna transcription
08/07/2003US20030148325 Infectious clones
08/07/2003US20030147937 Di-myo-inositol phosphate, cyclic 2,3 diphosphoglycerate, 1,1-di- glycerol phosphate, mannosylglycerate, mannosyl glyceramide and/or di-mannosyl-di-inositol phosphate; protecting organisms, organs, tissues, cells from oxidation
08/07/2003US20030147922 Vaccine against streptococcus pneumoniae capsular polysaccharides
08/07/2003US20030147903 ABC transport polynucleotides, polypeptides and antibodies
08/07/2003US20030147876 Combination of a growth factor and a protease enzyme
08/07/2003CA2714295A1 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003CA2514518A1 Process for the preparation of a nutrient formulation
08/07/2003CA2474908A1 Aggrecanase molecules
08/07/2003CA2474852A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis
08/07/2003CA2474719A1 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
08/07/2003CA2474690A1 Composition for inhalation
08/07/2003CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003CA2474277A1 2,4-pyrimidinediamine compounds and their uses
08/07/2003CA2473810A1 Fgfr agonists
08/07/2003CA2473803A1 Substituted indoles as alpha-1 agonists
08/07/2003CA2473249A1 New corticosteroids
08/07/2003CA2473128A1 Genetic polymorphisms in the preprotachykinin gene
08/07/2003CA2469571A1 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
08/07/2003CA2466915A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/07/2003CA2443023A1 8-heteroaryl xanthine adenosine a2b receptor antagonists
08/06/2003EP1332372A2 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression
08/06/2003EP1332151A1 Pyranoside derivatives
08/06/2003EP1332149A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
08/06/2003EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332144A1 Indole derivatives as pde5-inhibitors
08/06/2003EP1332136A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332132A2 Enamine derivatives as cell adhesion molecules
1 ... 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 ... 878